Ellenbecker Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Buy
11,031
+469
+4% +$12.3K 0.03% 126
2026
Q1
$297K Sell
10,562
-384
-4% -$10.2K 0.04% 106
2025
Q4
$273K Buy
10,946
+720
+7% +$18.2K 0.04% 107
2025
Q3
$261K Sell
10,226
-145
-1% -$3.58K 0.04% 106
2025
Q2
$251K Buy
10,371
+140
+1% +$3.27K 0.04% 101
2025
Q1
$259K Sell
10,231
-472
-4% -$12.4K 0.05% 97
2024
Q4
$284K Sell
10,703
-2,060
-16% -$55.9K 0.05% 92
2024
Q3
$369K Buy
12,763
+560
+5% +$16.3K 0.07% 75
2024
Q2
$341K Sell
12,203
-875
-7% -$24.1K 0.07% 86
2024
Q1
$363K Sell
13,078
-144
-1% -$4K 0.08% 77
2023
Q4
$380K Buy
13,222
+4,756
+56% +$144K 0.09% 67
2023
Q3
$280K Sell
8,466
-1,069
-11% -$37.8K 0.07% 77
2023
Q2
$349K Buy
9,535
+601
+7% +$23.4K 0.09% 66
2023
Q1
$364K Sell
8,934
-858
-9% -$37.1K 0.1% 61
2022
Q4
$501K Buy
9,792
+875
+10% +$42K 0.15% 49
2022
Q3
$390K Buy
8,917
+459
+5% +$22.3K 0.12% 50
2022
Q2
$443K Buy
8,458
+1,439
+21% +$73.3K 0.14% 48
2022
Q1
$363K Buy
7,019
+45
+0.6% +$2.33K 0.1% 59
2021
Q4
$411K Buy
6,974
+394
+6% +$19.5K 0.11% 54
2021
Q3
$283K Buy
6,580
+105
+2% +$4.65K 0.09% 59
2021
Q2
$254K Sell
6,475
-118
-2% -$4.59K 0.08% 62
2021
Q1
$239K Buy
6,593
+826
+14% +$29.3K 0.08% 62
2020
Q4
$212K Buy
+5,767
New +$212K 0.08% 64
2019
Q2
Sell
-5,081
Closed -$205K 56
2019
Q1
$205K Buy
5,081
+95
+2% +$3.81K 0.13% 53
2018
Q4
$207K Buy
4,986
+82
+2% +$3.4K 0.16% 50
2018
Q3
$205K Buy
+4,904
New +$189K 0.15% 50

Other funds holding PFE

Ellenbecker Investment Group's PFE Position: Q2 2026 in Review

Ellenbecker Investment Group increased its Pfizer (PFE) stake by 4.4% in Q2 2026, buying an estimated $12.3K and bringing the position to 11,031 shares worth $266K. The position accounts for 0.03% of the portfolio, ranked #126.

Ellenbecker Investment Group first reported a position in PFE in Q3 2018 and has held it in 26 quarters since. The position peaked at $501K in Q4 2022. 1,105 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ellenbecker Investment Group held 11,031 shares of Pfizer worth $266K as of Q2 2026.
  • Ellenbecker Investment Group bought 469 Pfizer shares in Q2 2026, an estimated $12.3K.
  • Pfizer made up 0.03% of Ellenbecker Investment Group's portfolio in Q2 2026, its #126 holding.
  • Ellenbecker Investment Group first reported a position in Pfizer in Q3 2018 and has held it in 26 quarters since.
  • Ellenbecker Investment Group's Pfizer position peaked at $501K in Q4 2022.
  • 1,105 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ellenbecker Investment Group's 13F filing for Q2 2026, filed 27 Jul 2026.